Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis
Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis
Not yet recruiting · NCT07756268 · Registry updated 2026-08-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-08-10 | NCT07756268 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CSPC Baike (Shandong) Bio-Pharmaceutical Co., Ltd. | 1 |
| Tongji Hospital | 276 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tongji Hospital, Tongji Medical College of Hust | Wuhan | China | 1 |